Yu-Sheng Chao

发表

A Machine Learning Approach to Case Adaptation

Alan Liu, Chieh-Kang Liao, Yu-Sheng Chao, 2018, 2018 IEEE First International Conference on Artificial Intelligence and Knowledge Engineering (AIKE).

JMC - Aurora - Supporting information - 2009

Mohane Selvaraj Coumar, Yu-Sheng Chao, Su-Ying Wu, 2013 .

JMC - Fast-forwarding Hit to Lead - Supporting information - 2010

Cheng-Wei Lin, Mohane Selvaraj Coumar, Yu-Sheng Chao, 2013 .

Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.

Po-Huang Liang, I-Lin Lu, Chih-Jung Kuo, 2006, Journal of medicinal chemistry.

Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.

I-Lin Lu, Chien-Fu Huang, Yu-Sheng Chao, 2005, Journal of medicinal chemistry.

Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.

Thy-Hou Lin, Po-Huang Liang, I-Lin Lu, 2006, Journal of medicinal chemistry.

Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists.

Ping-Chiang Lyu, I-Lin Lu, Yu-Sheng Chao, 2007, Journal of medicinal chemistry.

Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

Yu-Sheng Chao, Charlotte Burton, Ray Rosa, 2001 .

Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity.

Mohane Selvaraj Coumar, Yu-Sheng Chao, Su-Ying Wu, 2009, Journal of medicinal chemistry.

Putative tumor metastasis-associated genes in human gastric cancer.

Hsiao-Hui Tsou, Cheng-Ta Chung, Wen-Sen Lee, 2012, International journal of oncology.

Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.

Mohane Selvaraj Coumar, Yu-Sheng Chao, Su-Ying Wu, 2009, Journal of medicinal chemistry.

Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity

Cheng-Wei Yang, Hwan-You Chang, Hsing-Yu Hsu, 2017, Scientific Reports.

Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and Michael acceptor group for maximal potency.

Sing-Yi Wang, Mohane Selvaraj Coumar, Yu-Sheng Chao, 2010, Journal of medicinal chemistry.

Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.

Yu-Sheng Chao, Xiaohua Li, Y. Chao, 2005, Bioorganic & medicinal chemistry letters.

Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.

Ping-Chiang Lyu, Mohane Selvaraj Coumar, Yu-Sheng Chao, 2009, Journal of medicinal chemistry.

Structural Basis for the Improved Potency of Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists

Ping-Chiang Lyu, Mohane Selvaraj Coumar, Chien-Fu Huang, 2010, ChemMedChem.

Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies.

Ping-Chiang Lyu, I-Lin Lu, Ying-Ting Lin, 2006, Journal of medicinal chemistry.